Companion Diagnostics Market Size, Share and Forecast 2025
The global Companion Diagnostics market is segmented by Technology(Polymerase Chain Reaction, Next-Generation Sequencing)
(EMAILWIRE.COM, September 05, 2019 ) Market Overview:
The Companion Diagnostics Market was valued at USD xx million in 2017. The research at DMI yielded diverse opinions about the market with the global Companion Diagnostics market forecast valuation pegged at USD xx million by 2025.
The research also revealed that the global Companion Diagnostics Market size is expected to grow at a CAGR of xx% during the forecast period (2018-2025).
Market Dynamics:
The market is driven by several factors such as increased incidences of cancer, growing need for targeted therapies and favorable regulatory laws. The high cost of the drug development and lack of skilled professionals are the restraining factors that can affect the further growth of the market.
Market Segmentation:
The Companion Diagnostics market is segmented by Technology into:
• Polymerase Chain Reaction
• Next-Generation Sequencing
• In-situ Hybridization
• Immunohistochemistry
• Others
Based on Indications, the market is segmented into:
• Oncology (Colorectal Cancer, Leukemia, Breast Cancer, Lung Cancer, Others)
• Neurology
• Others
Based on End User, the market is segmented into:
• Pharmaceutical and Biopharmaceutical Companies
• Research Laboratories
• Others
Geographical Analysis:
Geographically, the market is segmented into:
• North America
• South America
• Europe
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players in the market includes:
• F. Hoffmann-La Roche AG
• Agilent Technologies Inc.
• Qiagen N.V.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories, Inc.
• Others
View full report: https://www.datamintelligence.com/research-report/companion-diagnostics-market
Download free sample: https://www.datamintelligence.com/download-sample/companion-diagnostics-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
The Companion Diagnostics Market was valued at USD xx million in 2017. The research at DMI yielded diverse opinions about the market with the global Companion Diagnostics market forecast valuation pegged at USD xx million by 2025.
The research also revealed that the global Companion Diagnostics Market size is expected to grow at a CAGR of xx% during the forecast period (2018-2025).
Market Dynamics:
The market is driven by several factors such as increased incidences of cancer, growing need for targeted therapies and favorable regulatory laws. The high cost of the drug development and lack of skilled professionals are the restraining factors that can affect the further growth of the market.
Market Segmentation:
The Companion Diagnostics market is segmented by Technology into:
• Polymerase Chain Reaction
• Next-Generation Sequencing
• In-situ Hybridization
• Immunohistochemistry
• Others
Based on Indications, the market is segmented into:
• Oncology (Colorectal Cancer, Leukemia, Breast Cancer, Lung Cancer, Others)
• Neurology
• Others
Based on End User, the market is segmented into:
• Pharmaceutical and Biopharmaceutical Companies
• Research Laboratories
• Others
Geographical Analysis:
Geographically, the market is segmented into:
• North America
• South America
• Europe
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players in the market includes:
• F. Hoffmann-La Roche AG
• Agilent Technologies Inc.
• Qiagen N.V.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories, Inc.
• Others
View full report: https://www.datamintelligence.com/research-report/companion-diagnostics-market
Download free sample: https://www.datamintelligence.com/download-sample/companion-diagnostics-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results